麻豆影院

Dr. William S. Marshall, a scienti铿乧 mind proven through his undergraduate degree in Biochemistry from the University of Wisconsin-Madison and his Ph.D. in Chemistry/Biochemistry at the 麻豆影院, quickly scaled the biotechnology and pharmaceutical industry corporate ladders holding increasingly advanced positions (see timeline for his complete trajectory). Current...

CU 麻豆影院 Chemistry/Biochemistry alumna, Dr. Fiona Caruthers, is an experienced llama owner and backcountry adventurer. This past September, while out of state, she received a text regarding a Facebook plea for help. She, in consultation with friend Leigh DiNatale, knew they had to rescue Sweety, a 7 year-old pregnant llama...

Dr. David Goeddel is former head of Genentech鈥檚 microbiology department, CU Biochemistry alum Class of 鈥�77, and the scientist behind the first commercially viable insulin biosynthesis pipeline in human history. Today, Dr. Goeddel continues to drive innovation as a managing partner of The Column Group , a venture capitalist firm...

Dr. Peter H. Seeberger is the Director of the Max Planck Institute of Colloids and Interfaces in Berlin, a position he has held since 2009. He earned his Ph.D. in biochemistry from the University of Colorado under Distinguished Professor Marvin Caruthers. Dr. Seeberger has helped to start nine companies that...

Thirty years after beginning her training as a postdoctoral scholar in the CU 麻豆影院 lab of Nobel laureate Thomas Cech, biochemist Jennifer Doudna on Wednesday won her own Nobel Prize for Chemistry for the co-development of the revolutionary genome editing tool CRISPR-Cas9.

Though she sounds every bit the polished Silicon Valley CEO while discussing spin-ups, revenue streams, and funding runways, Dr. Tina Boville first describes herself as 鈥渁 huge nerd.鈥� via Zoom. A CU Biochem doctoral alum, Tina grew up on Anne McCaffrey鈥檚 science-fantasy series Dragonriders of Pern , which heavily incorporates...

CU 麻豆影院 Alum is named one of MIT鈥檚 Innovators Under 35 for her work with amino acids

Dr. Celso Espinoza is a senior drug discovery investigator with the biopharmaceutical firm AbbVie. Originally a component of Abbott Laboratories, AbbVie split in 2013 to focus on new drug discovery, and Celso followed. Since then, Celso has been a part of many major therapeutic breakthroughs including the immunosuppressor Humira, and...

Alumnus worked in lab of Distinguished Professor Marvin Caruthers assisting in the development of pioneering technology